GHBP, IGF-1 and IGFBP-3 serum levels in familial short-statured and normal-statured children;Concentración sérica de GHBP, IGF-1 e IGFBP-3 en niños con talla baja familiar y con talla normal

Medicina Clinica

Volumn 123, Issue 12, 2004, Pages 452-455

  Del Valle Nuñez, Cristóbal Jorge ^a   López Siguero, Juan Pedro ^b   López Canti, Luis Fernando ^c   Lechuga Campoy, José Luis ^d   Espigares Martín, Rosa ^e   Martínez Aedo Ollero, Maria José ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b Hospital Clinico Carlos Haya   (Spain)

^c Hospital Vigil de Quinones   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Familial short statured patients; GHBP; IGF 1; IGFBP 3

Indexed keywords

GROWTH HORMONE BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; BONE AGE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GROWTH RATE; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; MALE; PARAMETER; PATHOPHYSIOLOGY; PREPUBERTY; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SHORT STATURE; STATISTICAL ANALYSIS;

EID: 8644259168     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13067086     Document Type: Article

References (30)

1. Albertsson-Wikland K, Rosberg S. Analysis of 24-hour growth hormone profiles in children: relation to growth. J Clin Endocrinol Metab 1988;67:493-500.
2. Blum WF, Albertsson-Wikland K, Rosberg S, Ranke M. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 1993;76:1610-6.
3. Hindmarsh P, Smith PJ, Brook CGD, Matthews DR. The relationship between height velocity and growth hormone secretion in short prepubertal children. Clin Endocrinol 1987;27:581-91.
4. Costin G, Kaufman FR, Brasel JA. Growth hormone secretory dynamics in subjects with normal stature. J Pediatr 1989;115:537-44.
5. Pozo J, Argente J, Barrios V, González-Parra S, Munoz MT, Hernández H. Growth hormone secretion in children with normal variants of short stature. Horm Res 1994;41:185-92.
6. Veldhuis JD, Blizzard RM, Rogol AD, Martha PM, Kirkland JL, Sherman BM and Genentech Collaborative Group. Properties of spontaneous growth hormone secretory bursts and half-life of endogenous growth hormone in boys with idiopathic short stature. J Clin Endocrinol Metab 1992;74;766-73,
7. Rose SR, Ross JL, Uriarte M, Barnes KM, Cassorla FG, Cutler GB. The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency. N Engl J Med 1988;319:201-7.
8. Martha PM, Rogol AD, Blizzard RM, Shaw MA, Baumann G. Growth hormone-binding protein activity is inversely related to 24-hour growth hormone release in normal boys, J Clin Endocrinol Metab 1991;73:175-81.
9. Gelander L, Bjarnason R, Carlsson LMS, Albertsson-Wikland K. Growth hormone-binding protein levels over one year in healthy prepubertal children: intraindividual variation and correlation with height velocity. Pediatr Res 1998;43:256-61.
10. Codner DE, Mericq MV, Maheshwari HG, Iñiguez G, Capurro MT, Salazar T, et al. Relationship between serum growth hormone binding protein levels and height in young men, J Pediatr Endocrinol Metab 2000;13:887-92.
11. Binoux M, Gourmelen M, Girard F. Serum levels of insulin growth factor (IGF) and IGF-binding protein in constitutionally short children and adolescents. Acta Endocrinol (Copenh) 1986;113:145-52,
12. Woods KA, Dastot F, Preece MA, Clark AJL, Postel-Vinay MC, Chatelain PG, et al. Phenotype: genotype relationships in growth hormone insensitivity syndrome. J Clin Endocrinol Metab 1997, 82:3529-35.
13. Ranke MB. Towards a consensus on the definition of idiopathic short stature. Horm Res 1996;45(Suppl 2):64-6.
14. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Childh 1976;51:170-9.
15. Hernández M, Castelet J, Narvaíza JL, Rincón JM, Ruiz I, Sánchez E, et al. Estudio longitudinal de crecimiento. Curvas de 0 a 18 años. Madrid: Garsi, 1988.
16. Gaidner D, Pearson J. A growth chart for premature and other infants. Arch Dis Childh 1971;46:783-7.
17. Llopis MA, Granada ML, Audí L, Sanmartí A, Bel J, Sánchez-Planell L, et al. Analytical performance and clinical usefulness of two binding assays for growth hormone binding protein (GHBP) measurement: high performance liquid chromatography (HPLC)-gel filtration and dextrancoated charcoal adsorption. Clin Chim Acta 1997;267:167-81.
18. Baumann G, Mercado M. Growth hormone-binding proteins in plasma. Nutrition 1993;9:546-53.
19. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocrine Rev 1994;15:80-101.
20. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, et al. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987:330:537-43.
21. Carlsson LMS, Attie KM, Compton PG, Vitangcol RV, Merimee TJ. Reduced concentration of serum growth hormone-binding protein in children with idiopathic short stature. J Clin Endocrinol Metab 1994;78:1325-30.
22. Attie KM, Carlsson LMS, Rundle AC, Sherman BM. Evidence for partial growth hormone insensitivity among patients with idiopathic short stature. J Pediatr 1995;127:244-50.
23. Baumann G, Shaw MA, Brumbaugh RC, Schwartz J. Short stature and decreased serum growth hormone-binding protein in the mountain Ok people of Papua New Guinea. J Clin Endocrinol Metab 1991;72:1346-9.
24. Merimee TJ, Baumann G, Daughaday W. Growth hormone-binding protein: II. Studies in Pygmies and normal statured subjects. J Clin Endocrinol Metab 1990;71:1183-8.
25. Martha PM, Reiter EO, Dávila N, Shaw MA, Holcombe JH, Baumann G. Serum growth hormone (GH)-binding protein/receptor: an important determinant of GH responsiveness. J Clin Endocrinol Metab 1992;75:1464-9.
26. Martha PM, Rogol AD, Blizzard RM, Shaw MA, Baumann G. Growth hormone-binding protein activity is inversely related to 24-hour growth hormone release in normal boys. J Clin Endocrinol Metab 1991;73:175-81.
27. Zadik Z, Amnon Z, Altman Y, Chen M. The effect of exogenous and endogenous growth hormone on plasma growth hormone binding activity in prepubertal children. Horm Res 1993;40:161-7.
28. Martha PM, Reiter EO, Dávila N, Shaw MA, Holcombe JH, Baumann G. The role of body mass in the response to growth hormone therapy. J Clin Endocrinol Metab 1992;75:1470-3.
29. Lewis MD, Horan M, Millar DS, Newsway V, Easter TE, Fryklund L, et al. A novel dysfunctional growth hormone variant (Ile179Met) exhibits a decreased ability to activate the extracellular signal-regulated kinase pathway. J Clin Endocrinol Metab 2004;89:1068-75.
30. Rosenfeld RG, Hwa V. Toward a molecular basis for idiopathic short stature [editorial]. J Clin Endocrinol Metab 2004;89:1066-7.